Chew Shun Chang, PhDSenior Director of Antibody Discovery at Daedamab, Alloy TherapeuticsSpeaker
Profile
Chew Shun, Chang. Ph.D. is a senior director of Antibody Discovery at Daedamab, Alloy Therapeutics. He has over 20 years of experience in the biopharmaceutical industry specializing in therapeutic monoclonal antibody discovery. His work focuses on streamlining the process of lead candidate therapeutic mAb discovery to IND filing.
Agenda Sessions
ATX-Gx Select: A New Mouse Strain That Can Identify Antigen Experienced B Cells in Situ to Facilitate Antibody Drug Discovery for Complex Therapeutic Targets
, 1:45pmView Session
